We continue to participate in protocols for the treatment of inflammatory bowel diseases: a portfolio of new studies on Crohn's disease and ulcerative colitis.
We continue to participate in protocols for the treatment of inflammatory bowel diseases: a portfolio of new studies on Crohn's disease and ulcerative colitis.